Skip to content
Medical Health Aged Care

Australia’s cost-of-living blind spot

October 10, 2024 3 mins read

Aussies are ignoring optometrist prescriptions at a concerning rate with a recent study suggesting that 18 per cent of people are not proceeding with an optical prescription or following through with treatment because of cost.

The findings may also suggest that some Australians may be unaware of what is covered under Medicare with 21 per cent saying they skip eye tests because of costs despite the reality that regular eye tests are fully covered for card holders.

Bupa Optical & Hearing Director, Adrian Kemp said it was concerning that some Australians may be needlessly going about their lives with vision impairments which may negatively impact their ability to be at their best at work, drive safely or learn to their full potential.

“Based on Australian Government data, over 13 million Aussies have one or more chronic eye conditions, however the number could be even higher with people skipping appointments and more worryingly, leaving prescriptions unfilled.

“Amidst the current cost-of-living environment, it’s vital people know that eye tests can be done quickly, can be bulk-billed for Medicare card holders and don’t require a GP’s referral. If work commitments are pressing, customers can access eye tests on weekends,” Adrian said.

To help support customer’s general health and household budgets, Bupa Optical is also offering a no out-of-pocket experience for Bupa Health Insurance members on Artificial Intelligence enabled eye assessments that can help detect risks of developing broader health issues such as cardiovascular disease, diabetes and a range of other conditions.

This Bupa Optical initiatives provides additional value for money at a time where studies suggest that 40 per cent of people avoid health services that are not covered by Medicare or private health insurance due to the costs involved.

The EyeInspect and Microvascular Health Assessment technology leans on the notion that the eye is a window into the heart as it is the only organ in the body where one can get a direct non-invasive view of a person’s blood vessels which can help identify an individual’s potential health risks.

“The Australian-first initiative is aimed at providing some relief against ongoing financial challenges for busy Australians while also encouraging preventive general health care.

“A visit to the optometrist can mean more than just testing for eye conditions such as short or long-sightedness along with age related macular degeneration and glaucoma. We can offer customers a service that can provide a preventative picture of their general health, which they can then discuss with their doctor... It’s all about using technology combined with our optometrists clinical expertise to help make healthcare more convenient and less fragmented,” Adrian said.

 

ENDS

 

Note to News Desks

 

Interviews available with Bupa Optical Optometrist Karen Makin

 

For more information, please contact:

 

Eli Grynberg                                                   
External Communications Manager, Bupa                             
Email:
[email protected]     

Mob: 0401 135 713                                                       

 

About Bupa Asia Pacific

Bupa is an international healthcare group which has been committed to a purpose of helping people live longer, healthier, happier lives and making a better world for more than 70 years.

Bupa Asia Pacific operates in Australia, New Zealand and Hong Kong, supporting about 7.3 million customers through a broad range of health and care services including health insurance, aged care, dental, medical, optical and hearing services.

Employing more than 22,000 people in the region, we believe that we can make a real difference to the lives of customers through our values, purpose and the way that we deliver personalised care.

Over the past 17+ years we have invested more than AUD$36 million in partnerships and programs focused on improving health of communities across Australia.



 

 

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.